Patents by Inventor Sreekant R. Nadkarni

Sreekant R. Nadkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIPLE ACTIVE DRUG RESIN CONJUGATE
    Publication number: 20080260845
    Abstract: A combination pharmaceutical preparation including two different active drugs of the same ionic charge conjugated with a single resin particle, without one significantly displacing the other, and without retarding the initial availability of either active. Also, methods for the manufacture of a multiple active drug-resin conjugate, and for the in vivo release of a combination of pharmaceutically active drugs from a multiple active drug-resin conjugate.
    Type: Application
    Filed: March 31, 2008
    Publication date: October 23, 2008
    Inventors: Deepak Thassu, Paul D. Hafey, Sreekant R. Nadkarni, Jatin S. Desai, Leo J. Magee
  • Dual-release compositions of a cyclooxygenase-2 inhibitor
    Patent number: 7220434
    Abstract: Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility, for example celecoxib, in an immediate-release fraction and a controlled-release, slow-release, programmed-release, timed-release, pulse-release, sustained-release or extended-release fraction. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: May 22, 2007
    Assignee: Pharmacia Corporation (of Pfizer, Inc.)
    Inventors: Subhash Desai, Sreekant R. Nadkarni, Randy J. Wald, Gary A. DeBrincat
  • Dual-release compositions of a cyclooxygenase-2 inhibitor
    Publication number: 20040242640
    Abstract: Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility, for example celecoxib, in an immediate-release fraction and a controlled-release, slow-release, programmed-release, timed-release, pulse-release, sustained-release or extended-release fraction. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
    Type: Application
    Filed: February 23, 2004
    Publication date: December 2, 2004
    Inventors: Subhash Desai, Sreekant R. Nadkarni, Randy J. Wald, Gary A. DeBrincat
  • Pharmaceutical composition exhibiting consistent drug release profile
    Publication number: 20040186105
    Abstract: An orally deliverable pharmaceutical composition comprises a drug of low water solubility and a pregelatinized starch having low viscosity and/or exhibiting a multimodal particle size distribution. A process for preparing such a composition comprises a step of selecting a pregelatinized starch having low viscosity and/or exhibiting a multimodal particle size profile, and a step of admixing the selected pregelatinized starch with a drug of low water solubility.
    Type: Application
    Filed: August 25, 2003
    Publication date: September 23, 2004
    Inventors: Carl T. Allenspach, Sreekant R. Nadkarni, Daryl A. Roston, Brian R. Rohrs, Roxana F. Schlam